Clicky

Your daily coffee may protect your brain, according to a 43-year study

 

A large prospective cohort study by researchers at Mass General Brigham, the Harvard TH Chan School of Public Health and the Broad Institute of MIT and Harvard examined data from 131,821 participants in the Nurses’ Health Study (NHS) and the Health Professionals Follow-Up Study (HPFS). The results showed that moderate intake of caffeinated coffee (2–3 cups a day) or tea (1–2 cups a day) was associated with a lower risk of dementia, slower cognitive decline and better preservation of cognitive abilities. The study was published in JAMA.

“When we were looking for possible tools for preventing dementia, we thought something as widespread as coffee might be a promising dietary intervention – and our unique access to high-quality data from studies that have been running for more than 40 years allowed us to pursue that idea,” said senior author Daniel Wang, MD, ScD, associate scientist in the Channing Division of Network Medicine in the Mass General Brigham Department of Medicine and assistant professor at Harvard Medical School. Wang is also an assistant professor in the Department of Nutrition at the Harvard Chan School and an associate member of the Broad Institute. “Although our results are encouraging, it’s important to remember that the effect size is small and there are many important ways to protect cognitive function as we age. Our study suggests that drinking caffeinated coffee or tea may be one piece of that puzzle.”

Why prevention matters for dementia

Preventing dementia early is especially important because current treatments are limited and generally provide only modest benefits after symptoms appear. As a result, scientists are increasingly focusing on lifestyle factors, including diet, that may influence the development of cognitive decline.

Coffee and tea contain compounds such as polyphenols and caffeine, which are thought to support brain health. These substances may help reduce inflammation and limit cell damage, both of which are linked to cognitive decline. However, previous research on coffee and dementia has produced conflicting results, often because of shorter study periods or limited data on long-term consumption patterns and different types of drinks.

Long-term data offer clearer insights

The NHS and HPFS datasets helped fill these gaps. Participants were followed for up to 43 years, with repeated assessments of diet, dementia diagnoses, subjective cognitive concerns and objective cognitive performance. The researchers analyzed how the consumption of caffeinated coffee, tea and decaffeinated coffee related to long-term brain health outcomes.

Of the more than 130,000 participants, 11,033 developed dementia over the course of the study. Individuals who consumed larger amounts of caffeinated coffee had an 18% lower risk of developing dementia than those who drank it rarely or never. They also reported lower rates of subjective cognitive decline (7.8% vs. 9.5%) and performed better on some objective cognitive tests.

Caffeine may play a key role

Similar patterns were seen among tea drinkers, whereas decaffeinated coffee did not show the same associations. This suggests that caffeine may be an important factor behind the observed brain-related benefits, although further research is needed to confirm the underlying mechanisms.

The strongest effects were seen in participants who drank 2–3 cups of caffeinated coffee or 1–2 cups of tea a day. Higher levels of caffeine intake did not appear to cause harm. Instead, they showed benefits comparable to the moderate intake range highlighted in the study.

“We also compared people with different genetic predispositions to developing dementia and saw the same results – which means that coffee or caffeine is likely equally beneficial for people at high and low genetic risk of developing dementia,” said lead author Yu Zhang, MBBS, MS, a doctoral student at the Harvard Chan School and research trainee at Mass General Brigham.

Study authors and funding

In addition to Wang and Zhang, Mass General Brigham contributors included Yuxi Liu, Yanping Li, Yuhan Li, Jae H. Kang, A. Heather Eliassen, Molin Wang, Eric B. Rimm, Frank B. Hu and Meir J. Stampfer. Additional authors were Walter C. Willett and Xiao Gu.

The research was supported by National Institutes of Health grants UM1 CA186107, U01 HL145386, U01 CA167552, R01 HL60712, P30 DK46200, R00 DK119412, R01 AG077489, RF1 AG083764 and R01 NR019992. The funding organizations were not involved in the study design, data collection, analysis, manuscript preparation or the decision to publish.

Source link

Cosa vuoi trovare?